BOGLE INVESTMENT MANAGEMENT L P /DE/ - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$958,000
-65.0%
174,512
-63.3%
0.06%
-67.5%
Q2 2017$2,739,000475,6020.20%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$6,282,0002.96%
COURAGE CAPITAL MANAGEMENT LLC 100,000$527,0000.33%
Crawford Lake Capital Management, LLC 69,100$364,0000.26%
Hall Kathryn A. 31,355$166,0000.20%
ELLINGTON MANAGEMENT GROUP LLC 29,300$154,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$116,0000.02%
Virtu KCG Holdings LLC 150,357$792,0000.02%
THOMPSON DAVIS & CO., INC. 2,000$11,0000.02%
Jasper Ridge Partners, L.P. 47,481$250,0000.02%
AXA S.A. 479,686$2,528,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders